Abstract
In the study, we aimed to show the effects of vitamin B12 on the necrosis caused by methotrexate (MTX), a folic acid antagonist. Thirty-two rats were randomly assigned to four groups of eight rats per group. Control (n = 8), Vit B12 (n = 8) 3 μg/kg/ip B12 (15 days) per day throughout the experiment, MTX (n = 8) injected with a single dose of 20 mg/kg/ip MTX on 8th day of experiment, MTX + Vit B12 (n = 8) injected with a single dose of 20 mg/kg ip methotrexate on 8th day of experiment + 3 μg/kg/ip Vit B12 (15 days) per day throughout the experiment. Oxidant (TOS)/antioxidant (TAS) system, TNF-α and TGF-β levels, AST and ALT, serum vitamin B12 levels were determined in the tissue. Cyclooxygenase-2 (Cox-2), receptor-interacting protein kinase 1 (RIP1) and 3 (RIP3) immunohistochemistry were applied to the liver tissue. TOS increased; TAS decreased; TNF-α and TGF-β levels increased; AST and ALT levels changed after MTX hepatotoxicity. Vit B12 decreased significantly. COX-2, RIP1, and RIP3 immunoreactivity increased. Vit B12 showed improvement in all of the negative results. Vit B12 is an important supplement to be used against necrosis in tissue after MTX hepatotoxicity.
Similar content being viewed by others
References
Al Maruf A, O’Brien PJ, Naserzadeh P, Fathian R, Salimi A, Pourahmad J (2018) Methotrexate induced mitochondrial injury and cytochrome c release in rat liver hepatocytes. Drug Chem Toxicol 41:51–61. https://doi.org/10.1080/01480545.2017.1289221
Ali N, Rashid S, Nafees S, Hasan SK, Shahid A, Majed F, Sultana S (2017) Protective effect of chlorogenic acid against methotrexate induced oxidative stress, inflammation and apoptosis in rat liver: an experimental approach. Chem Biol Interact 272:80–91. https://doi.org/10.1016/j.cbi.2017.05.002
Borish LC, Steinke JW (2003) 2. Cytokines and chemokines. J Allergy Clin Immunol 111:S460–S475. https://doi.org/10.1067/mai.2003.108
Brenner C, Galluzzi L, Kepp O, Kroemer G (2013) Decoding cell death signals in liver inflammation. J Hepatol 59:583–594. https://doi.org/10.1016/j.jhep.2013.03.033
Bu T et al (2018) Hepatoprotective effect of rhein against methotrexate-induced liver toxicity. Eur J Pharmacol 834:266–273. https://doi.org/10.1016/j.ejphar.2018.07.031
Calvert H (2002) Folate status and the safety profile of antifolates. Semin Oncol 29:3–7. https://doi.org/10.1016/s0093-7754(02)70209-1
Cetin A et al (2008) Role of grape seed extract on methotrexate induced oxidative stress in rat liver. Am J Chin Med 36:861–872. https://doi.org/10.1142/s0192415x08006302
Chan ES, Cronstein BN (2010) Methotrexate--how does it really work? Nat Rev Rheumatol 6:175–178. https://doi.org/10.1038/nrrheum.2010.5
Demiryilmaz I et al (2012) Biochemically and histopathologically comparative review of thiamine’s and thiamine pyrophosphate’s oxidative stress effects generated with methotrexate in rat liver. Med Sci Monit 18:Br475–Br481. https://doi.org/10.12659/msm.883591
Eki Nci-Akdemi RF, Yildirim S, Kandemi RF, Gülçi Nİ, Küçükler S, Sağlam YS, Yakan S (2018) The effects of casticin and myricetin on liver damage induced by methotrexate in rats. Iran J Basic Med Sci 21:1281–1288. https://doi.org/10.22038/ijbms.2018.29922.7217
Ewees MG, Abdelghany TM, Abdel-Aziz AH, Abdelbakky MS (2019) Enoxaparin prevents fibrin accumulation in liver tissues and attenuates methotrexate-induced liver injury in rats. Naunyn Schmiedeberg's Arch Pharmacol 392:623–631. https://doi.org/10.1007/s00210-019-01618-1
Feoktistova M, Leverkus M (2015) Programmed necrosis and necroptosis signalling. FEBS J 282:19–31. https://doi.org/10.1111/febs.13120
Gisondi P, Fantuzzi F, Malerba M, Girolomoni G (2007) Folic acid in general medicine and dermatology. J Dermatolog Treat 18:138–146. https://doi.org/10.1080/09546630701247930
Greibe E, Nymark O, Fedosov SN, Heegaard CW, Nexo E (2018) Dietary Intake of vitamin B12 is better for restoring a low B12 status than a daily high-dose vitamin pill: an experimental study in rats. Nutrients 10. https://doi.org/10.3390/nu10081096
Halsted CH (2013) B-Vitamin dependent methionine metabolism and alcoholic liver disease. Clin Chem Lab Med 51:457–465. https://doi.org/10.1515/cclm-2012-0308
Lambie DG, Johnson RH (1985) Drugs and folate metabolism. Drugs 30:145–155. https://doi.org/10.2165/00003495-198530020-00003
Lu SC (2000) S-Adenosylmethionine. Int J Biochem Cell Biol 32:391–395. https://doi.org/10.1016/s1357-2725(99)00139-9
Lu SC, Mato JM (2012) S-adenosylmethionine in liver health, injury, and cancer. Physiol Rev 92:1515–1542. https://doi.org/10.1152/physrev.00047.2011
Mager DR (2015) Methotrexate. Home Healthc Now 33:139–141. https://doi.org/10.1097/nhh.0000000000000203
Mohamed DI, Khairy E, Tawfek SS, Habib EK, Fetouh MA (2019) Coenzyme Q10 attenuates lung and liver fibrosis via modulation of autophagy in methotrexate treated rat. Biomed Pharmacother 109:892–901. https://doi.org/10.1016/j.biopha.2018.10.133
Newton K (2015) RIPK1 and RIPK3: critical regulators of inflammation and cell death. Trends Cell Biol 25:347–353. https://doi.org/10.1016/j.tcb.2015.01.001
Nikseresht S, Khodagholi F, Ahmadiani A (2017) Actors of necroptosis scenario in cell’s scene. Physiol Pharmacol 21:88–101
Núñez Martínez O, Clemente Ricote G, García Monzón C (2003) Role of cyclooxygenase-2 in the pathogenesis of chronic liver diseases. Med Clin (Barc) 121:743–748. https://doi.org/10.1016/s0025-7753(03)74082-2
OECD (2000) Environment Directorate, Joint Meeting of The Chemicals Committee and The Working Party on. Chemicals, Pesticides and Biotechnology
Öztürk E, Kaymak E, Akin AT, Karabulut D, Ünsal HM, Yakan B (2020) Thymoquinone is a protective agent that reduces the negative effects of doxorubicin in rat testis Hum Exp Toxicol:960327120924108 https://doi.org/10.1177/0960327120924108
Pannérec A et al (2018) Vitamin B12 deficiency and impaired expression of amnionless during aging. J Cachexia Sarcopenia Muscle 9:41–52. https://doi.org/10.1002/jcsm.12260
Pınar N, Kaplan M, Özgür T, Özcan O (2018) Ameliorating effects of tempol on methotrexate-induced liver injury in rats. Biomed Pharmacother 102:758–764. https://doi.org/10.1016/j.biopha.2018.03.147
Puig L (2014) Methotrexate: new therapeutic approaches. Actas Dermosifiliogr 105:583–589. https://doi.org/10.1016/j.ad.2012.11.017
Samdanci ET, Huz M, Ozhan O, Tanbek K, Pamukcu E, Akatli AN, Parlakpinar H (2019) Cytoprotective effects of molsidomine against methotrexate-induced hepatotoxicity: an experimental rat study. Drug Des Devel Ther 13:13–21. https://doi.org/10.2147/dddt.S181550
Sayan M, Karabulut D, Özdamar S (2020) Assessment of the protective and therapeutic effect of melatonin against thioacetamide-induced acute liver damage. J Biochem Mol Toxicol:e22450
Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G (2010) Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol 11:700–714. https://doi.org/10.1038/nrm2970
Vezmar S, Becker A, Bode U, Jaehde U (2003) Biochemical and clinical aspects of methotrexate neurotoxicity. Chemotherapy 49:92–104. https://doi.org/10.1159/000069773
Yucel Y et al (2017) The effects of lycopene on methotrexate-induced liver injury in rats. Bratisl Lek Listy 118:212–216. https://doi.org/10.4149/bll_2017_042
Funding
This work was supported by Erciyes University the Scientific Research Projects Unit, TSA-2019-8673 project code.
Author information
Authors and Affiliations
Contributions
DK and EO designed and performed experiment. DK, ATA, EK, and BY contributed to analyzed the data. EO and NK performed the histological analyses. DK wrote the manuscript. The authors declare that all data were generated in-house and that no paper will was used.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
Ethical approval for the study was obtained from Erciyes University Animal Research Local Ethics Committee and the ethics at regulations were followed in accordance with national and institutional guidelines (date 2018, decision no. 18/116).
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Karabulut, D., Ozturk, E., Kuloglu, N. et al. Effects of vitamin B12 on methotrexate hepatotoxicity: evaluation of receptor-interacting protein (RIP) kinase. Naunyn-Schmiedeberg's Arch Pharmacol 393, 2473–2480 (2020). https://doi.org/10.1007/s00210-020-01992-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-020-01992-1